Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05450952 · ClinicalTrials.gov registry record · NA
Evaluate the Effects of a Theanine Formulation on Stress, Burnout, Mood, and Sleep in Individuals Who Report Occasional Moderate or High Levels of Stress
A NA study, sponsored by Supplement Formulators.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05450952 is a NA study that was terminated before completion, run by Supplement Formulators. The registered enrollment target is 14 participants.
The verdict
NCT05450952, a NA study, was terminated before completion, sponsored by Supplement Formulators.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness and safety of the theanine formulation on stress, burnout, mood, and sleep in male and female subjects who are generally healthy
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Theanine Formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2022-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05450952
The ClinicalTrials.gov registry entry for NCT05450952 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Supplement Formulators, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05450952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05450952 about?
NCT05450952 is a clinical study titled "Evaluate the Effects of a Theanine Formulation on Stress, Burnout, Mood, and Sleep in Individuals Who Report Occasional Moderate or High Levels of Stress". The purpose of this study is to assess the effectiveness and safety of the theanine formulation on stress, burnout, mood, and sleep in male and female subjects who are generally healthy
What is the current status of trial NCT05450952?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2022-04-21. Estimated completion is 2022-12-22.
What interventions are being tested in trial NCT05450952?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Theanine Formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05450952?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.